Research News - November 19, 2021

 

         
 
November 19, 2021
ANNOUNCEMENTS
 

1. MGH Research Job Board
2. Vote Today for the 2021 ECOR Elections for Representatives from the MGH Research Community!
3. Breaking Down Structure: How are major specialty departments organized? | On-Demand Innovation Education: MESH Core Healthcare Innovation Bootcamp
4. Network Access Control Requirements
5. COVID-19 Testing during Thanksgiving week

EVENTS
 

1. Fun Fridays- Chair/Office Yoga
2. Two Meditation Sessions available every week
3. Biobank Portal
4. Panel on Combatting Procrastination
5. Informed Consent Including eConsent
6. Introduction to the RPDR
7. Qualitative Interviewing
8. REDCap Survey Features and Functionality
9. Human Subjects Research Recordkeeping and Record Retention
10. Novelline Innovation Speaker Series

FUNDING OPPORTUNITIES
 

1. COVID Funding Opportunities
2. Interim Support Funding 22-1
3. Smith Family Foundation Odyssey Award
4. 2022 Blavatnik Therapeutics Challenge Awards
5. Familial RUNX1 Grant Program: RUNX1 Early Career Investigator Grant Program, Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)
6. NIH Research Supplements to Promote Diversity in Health-Related Research
7. Hanna H. Gray Fellows Program
8. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592
9. Limited Submission Funding Opportunities
10. Foundation Funding Opportunities

In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events
 
ANNOUNCEMENTS
 
1. MGH Research Job Board

Are you looking for a new opportunity within the Mass General Research Institute or hoping to promote a newly posted job within your department?  Check out the Research Job Board, powered by the Division of Clinical Research!

All members of the community are able to submit postings or apply for positions. 

Click here to learn more.

 
2. Vote Today for the 2021 ECOR Elections for Representatives from the MGH Research Community!

Elected representatives serve a 3-year term and will represent faculty concerns and issues.  ECOR representatives should be able to speak to your interests and concerns in discussions and planning for research at MGH.  To learn more about the candidates, click here.
Please cast your vote for one candidate from each category.

Assistant Professor Candidates

  • Jocelyn Carter, MD, MPH, Medicine, Division of General Internal Medicine
  • Anahita Dua, MD, MS, MBA, Surgery, Division of Vascular and Endovascular Surgery
  • Nitya Jain, PhD, Pediatrics, The Mucosal Immunology & Biology Research Centre

Professor Candidates:

  • Alessio Fasano, MD, Pediatrics, Division of Pediatric Gastroenterology and Nutrition
  • Jill Goldstein, PhD, Psychiatry / Medicine, Innovation Center on Sex Differences in Medicine
  • Judy Hung, PhD, Medicine, Division of Cardiology

Click here to vote
Please note: In order to vote you must be a Principal Investigator at the level of Assistant, Associate or Full Professor.

 
3. Breaking Down Structure: How are major specialty departments organized? | On-Demand Innovation Education: MESH Core Healthcare Innovation Bootcamp

In this free, pre-recorded on-demand session Dr. James Brink, Radiologist-in-Chief at the Massachusetts General Hospital and the Juan M. Taveras Professor of Radiology at Harvard Medical School, looks at the MGH Department of Radiology as a case study in how major hospital departments are organized and some of the critical elements needed for success. This session provides an overview of the clinical operations, governance structures, and research programs within the department, and highlights the necessary leadership skills required to manage such a large and complex structure. 

Sign-up and then enroll in the full innovation bootcamp certificate course or take just this session. Be sure to use your Mass General Brigham email and username.

 
4.  Network Access Control Requirements

Network Access Control (NAC) is a component of the security strategy Mass General Brigham is implementing to strengthen visibility and security of data and devices connected to the Mass General Brigham network. The agent currently used at Mass General Brigham is ForeScout SecureConnector. SecureConnector is already installed on Standard Windows PCs and PEAS-enrolled Macs. Today, the SecureConnector agent must be installed on any device connecting from campus at Assembly Row, Spaulding Navy Yard as well as McLean Hospital. Are you traveling to or working from one of those sites?

Visit rc.partners.org/computer to learn how to check if you have SecureConnector and install the appropriate agent for your device.

 
5. COVID-19 Testing during Thanksgiving week

Mass General Brigham COVID-19 testing sites will operate on a reduced schedule over the Thanksgiving holiday week. Employees who require pre-Thanksgiving elective COVID-19 testing should get tested before Wednesday, November 24. Employees can self-schedule their COVID-19 test via COVID Pass.

A full list of testing sites across Massachusetts (inside and outside of Mass General Brigham) can be found here, while New Hampshire testing sites can be found here. Learn more on The Pulse.

 
Back to top
EVENTS
 
1. Fun Fridays- Chair/Office Yoga

Friday, November 19, 2021, 12:00 – 1:00 PM, Zoom

Sponsored by the Center for Faculty Development’s Office for Well-Being

Chair yoga can be done in the comfort of your own office or home. You’ll practice relaxing breathing techniques and mindful movements to help relieve physical tension, quiet your mind and calm your spirit. No previous yoga experience is needed.

Facilitator: Laura Malloy, LICSW, C-IAYT, is a Kripalu yoga teacher, yoga therapist and clinical social worker

Click to register

 
2. Two Meditation Sessions available every week

Monday, November 22 & Wednesday, November 24, 2021, Zoom

Co-sponsored by the Center for Faculty Development’s Office for Well-Being and the MGPO Frigoletto Committee

Join Darshan Mehta, MD, MPH, Director, Office for Well-Being for a guided meditation session on Monday mornings. 
Register and add to calendar

SESSION 2: Midweek Meditation with Guest Leader 
Every Wednesday, 8:00 – 8:30 am, Zoom à next session, Wednesday, November 24!
Sponsored by the Center for Faculty Development’s Office for Well-Being

Join guest leader, Neena Haider, PhD, Department of Ophthalmology, for next Wednesday’s guided meditation session on November 24th!
Register and add to calendar

 
3. Biobank Portal

Wednesday, November 24, 2021, 10:00 – 11:00 AM, Zoom

The Partners Biobank Portal is a tool that links consented subjects from the Partners Biobank with their health care data from the electronic medical record (EMR) and allows researchers to request clinical samples for these subjects. 

This course will provide an introduction to the use of the Biobank Portal application for clinical research, including the review of healthcare data, types of samples available, genomic information and requesting data. The course is geared toward investigators and staff at all levels interested in the utility and information of the Biobank Portal for research.

Register here. Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.

 
4. Panel on Combatting Procrastination

Tuesday, November 30, 2021, 12:00 – 1:00 PM, Zoom

Sponsored by the Center for Faculty Development

When it comes time to sit down and write a manuscript of any kind, do you find many other things to do instead? Attend this presentation on how to combat procrastination. Three senior faculty will share the strategies they use to leap the hurdle of procrastination and get down to writing.

Learning Objectives:
Upon completion of this activity, participants will be able to:

  1. Know several strategies to overcome procrastination.
  2. Be able to use several techniques to identify thoughts that can lead to procrastination.
  3. Identify emotional sources of procrastination.

Panelists
Andrew Nierenberg, MD, Director, Dauten Family Center for Bipolar Treatment Innovation, MGH Professor of Psychiatry
Elyse Park, PhD, Program Director, Cancer Center Smokefree Support Service, MGH Professor of Psychiatry & Medicine
Nancy Tarbell, MD, Former HMS Dean for Academic and Clinical Affairs, CC Wang Professor of Radiation Oncology

Click here to register

 
5. Informed Consent Including eConsent

Wednesday, December 1, 2021, 1:00 – 2:30 PM, Zoom

Speaker: Pamela Richtmyer, Director, Partners Human Research Quality Improvement Program

This course is intended for investigators and research staff.  In addition to covering the required elements of the informed consent, this course will address the following:

  • Different options available for obtaining consent
  • Tips for writing an effective consent  
  • Documentation required for obtaining consent
  • ICF Recordkeeping   
  • Special Considerations

Register here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more.

 
6. Introduction to the RPDR

Thursday, December 2, 2021, 11:00 – 12:30 PM, Zoom

The Research Patient Data Registry (RPDR) brings clinical information to the researcher's fingertips and ensures the security of patient information by controlling and auditing the distribution of patient data within the guidelines of the IRB.

This course will provide an introduction to the use of the RPDR (Research Patient Data Registry) application for clinical research, including the review of healthcare data, creating a query and requesting data. The course is geared toward investigators and staff at all levels interested in the utility and information of the RPDR for research.

Register here. Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.

 
7. Qualitative Interviewing

Thursday, December 2, 2021, 3:00 – 4:00 PM, Zoom

Sponsored by the MGH Division of Clinical Research and the Mongan Institute of Health Policy

Speaker: Christina Psaros, PhD
This one session course is designed to guide clinical researchers who are interested in learning qualitative interviewing skills for individual interviews as well as focus groups. Topics may include: probing, asking open ended questions, using open- vs. close-ended questions, maintaining interview length and pace, and addressing challenging participant behaviors and non-judgmentally. This course is appropriate for all research staff who may engage in qualitative interviewing, including clinical research coordinators.  *Please note this course is only offered to MGH faculty and staff

Apply here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more.

 
8. REDCap Survey Features and Functionality

Friday, December 3, 2021, 10:00 – 11:00 AM, Zoom

REDCap Representatives: Lynn Simpson, Research Data Collection Services Manager, Jeremy Alphonse, Research Data Collection Services Project Analyst, Research Information Science and Computing (RISC) Applications and Services

Learn how to create, send and collect research data using the REDCap Survey feature.
REDCap surveys provide a powerful tool for collecting responses from survey participants by 1) emailing or texting a link to your survey, 2) entering data direct on a tablet/kiosk, and/or 3) posting a links on websites. We will also review Responsy, which is a Mass General Brigham secure mobile platform for REDCap survey collection.

This is open to all employees who work within the Mass General Brigham network.
REDCap link : https://rc.partners.org/research-apps-and-services/collect-data#redcap

Register here. Please contact tmorrison-rohlfs@partners.org with questions.

 
9. Human Subjects Research Recordkeeping and Record Retention

Friday, December 3, 2021, 10:00 – 11:30 AM, Zoom

Speaker: Pamela Richtmyer, Director, Human Research Affairs Compliance and Education Office

Investigators are required to maintain records of their human research activities. Good recordkeeping is essential for verifying the integrity of study data produced and for demonstrating investigator compliance with applicable regulations, and institutional policies and procedures.  This presentation will cover: recordkeeping requirements for regulatory and subject files, maintenance and storage options, common errors identified in inspections and audits, as well as retention requirements for study files.  

Register here. Please contact Tiereny Morrison-Rohlfs with questions.

Click here to learn more.

 
10. Novelline Innovation Speaker Series

Friday, December 3, 2021, 12:00 PM, Zoom

The Healthcare Transformation Lab is pleased to announce that we will host the next on-line presentation of our Novelline Innovation Speaker Series on 3 December at noon.  This next session features Aaron Martin.  Aaron Martin is the Executive Vice President and Chief Digital and Innovation Officer for Providence where he leads Digital, Marketing, and Ventures for Providence.  His presentation is titled:  Innovation at Scale | Platforms, Partners and Business Models that Work.

More information about the presentation and how to register for this event are located here.

Contact us at hctransformationlab@partners.org if you have questions.

 
Back to top
FUNDING OPPORTUNITIES
 
1. COVID Funding Opportunities

Please visit the new MGB web page for COVID funding opportunities that provides a central database for researchers to view open and competitive funding announcements.

We have aggregated opportunities from federal and private funding sources including NIH, DoD, CDC, EPA, foundations, and more.  The database defaults to sorting by award amount and can also be sorted by deadline or filtered by research focus.

Upcoming deadlines:

  • No upcoming deadlines

Recently added:

 
2. Interim Support Funding 22-1

The Executive Committee on Research (ECOR) is now accepting applications for Interim Support Funding. 

What are they?
Interim Support Funding
The Interim Support Funding (ISF) Program is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense).  Investigators must have applied for independent, long-term support (R01, R21, U01 and P01). The intent of the program is to rescue strong scientific programs that are in need of bridge funding in order to sustain their research. Applications will be accepted regardless of percentile or score, including applications that were not discussed. Financial need and the impact of the COVID pandemic will be taken into account.

When is the deadline?
Wednesday, December 1, 2021 - 5:00 PM

How do I learn more and apply?
Interim Support Funding - Click here

 
3. Smith Family Foundation Odyssey Award

A program of the Richard and Susan Smith Family Foundation

What are they?
The Smith Family Foundation Odyssey Award was created in 2017 to fuel creativity and innovation in junior investigators in the basic sciences.  The Award supports the pursuit of high impact ideas to generate breakthroughs and drive new directions in biomedical research.  The awards will fund high-risk, high-reward pilot projects solicited from our brightest junior faculty in the region. Projects should be conceptualized as a novel research line and a distinct and novel off-shoot from the applicant’s current research.

Eligible applicants must be junior investigators who received their first independent faculty appointment on or between November 1, 2013 and November 1, 2018.

There is no longer a limit on the number of applications from a given institution. Applicants no longer need to be internally selected and nominated by their institutions. Please apply directly to the sponsor.

How much is the award?
The award is $300,000 over two years ($150,000 per year).

When is the deadline?  
Tuesday, January 4, 2022 at 12:00 Noon

How do I learn more about the opportunity?
Smith Family Foundation: Odyssey Award – Click here

 
4. 2022 Blavatnik Therapeutics Challenge Awards

The Blavatnik Therapeutics Challenge Awards are part of the historic $200 million commitment from the Blavatnik Family Foundation to HMS. This will help propel the School’s mission of transforming health through curiosity-driven research that stimulates the development of new therapies and the creation of new tools to diagnose, prevent, and treat disease.

What is the Award?
The intent of these awards is to accelerate the development of therapeutics throughout HMS and its affiliated hospitals, with the goal of achieving licensable intellectual property and potentially creating new companies within a two-year time frame. The awards program will help investigators overcome obstacles to commercial translation by funding promising technologies and positioning them to attract venture and industry partners. Awards will include significant financial resources in addition to therapeutic development and project management expertise.

All faculty at the rank of assistant, associate, or full professor in the Harvard Faculty of Medicine (i.e., faculty at HMS, HMS-affiliated institutions, and HSDM) are eligible to apply for funding as lead PI. Collaborations are encouraged to create the appropriate team for translating the early-stage discovery to licensable intellectual property within the two-year award period. The Blavatnik Family Foundation will provide the funds for the awards, which will be administered by Harvard via a grant to the PI’s institution and funded at a level of up to $1 million (total costs) over a period of two years. It is anticipated that up to five new awards will be made in the 2022 program cycle.

When is the deadline?
Pre-proposals due by December 15, 2021, at 5 p.m.

How do I learn more about this opportunity?
More details on the RFP and submission process are attached and can be found on the program website: https://btca.hms.harvard.edu.

For questions about the submission, review, and selection process for pre-proposals, contact Ifat Rubin-Bejerano (ifat_rubin-bejerano@hms.harvard.edu ), HMS director of translational research programs.

 
5. Familial RUNX1 Grant Program: RUNX1 Early Career Investigator Grant Program, Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF)

To promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding to where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention.

Aims of research proposals must be relevant to the ultimate goal of preventing hematologic malignant transformation in RUNX1-FPD. Proposals that seek to translate from bench to bedside will receive priority.

Example areas of research interests include:

  • Hematopoietic stem cell gene correction strategies that optimize gene editing efficiency, precision and limit off-target effects.
  • Determining the drivers of clonal hematopoiesis and progression to overt malignancy.
  • Identifying strategies to lower the risk of hematologic malignancy in RUNX1-FPD.
  • Understanding the cellular and molecular mechanisms that underlie the inflammatory manifestations of RUNX1-FPD such as eczema, reactive airway disease and GERD.
  • Defining the role of inflammation in leukemic progression in RUNX1-FPD.
  • Determining whether impaired RUNX1-regulated DNA damage response contributes to acquisition of somatic mutations and clonal evolution.

Eligibility requirements (partial list):

  • Applicants must have an MD, PhD or dual MD, PhD (DO, MBBS or equivalent) and be within 5 years of their first faculty appointment as an Assistant Professor or equivalent.
  • Applicants may have research grants from other funding sources during the award period, but there must be clear documentation of mechanisms to avoid scientific and budgetary overlap.
  • Applicants must have research experience working in and a deep understanding of normal or malignant hematopoiesis and/or immunology.
  • One resubmission of a previously unfunded application is allowed. 

Citizenship: Unrestricted

Award Amount: $180,000 paid over 3 years
Indirect Costs: None
Research Management Deadline: December 8, 2021
Application Deadline: December 20, 2021


Click here to visit the website and to learn more.
 
6. NIH Research Supplements to Promote Diversity in Health-Related Research

Fostering diversity in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital NOT-OD-20-031.

This administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level. Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce.

Please click here to learn more.

 
7.  Hanna H. Gray Fellows Program

Applications are now being accepted by the Howard Hughes Medical Institute for the Hanna H. Gray Fellows Program

What is it?
The goal of the Hanna H. Gray Fellows Program is to recruit and retain individuals from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those individuals from disadvantaged backgrounds. Fellows receive funding to support their postdoctoral training and may continue to receive funding during their early career years as independent faculty. Fellows participate in professional development, mentorship, and networking with their community of peers and the broader HHMI community of scientists across career stages.

How much is each award?
Up to 25 Hanna Gray Fellows are selected annually. During the postdoctoral trainee phase, a minimum of 2 years, fellows will receive annual support of a $70,000 salary for the initial year and a $20,000 expense allowance, paid through the training institution. During the faculty phase,  fellows will receive $250,000 in research funding and a $20,000 expense allowance per year, maximum of 4 years, paid through the institution where they have attained a faculty position.

When is the deadline
December 1, 2021: Applications are due
December 8, 2021: Mentor and reference letters are due
How do I learn more and apply?

 
8. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592

The primary mission of this program is to promote the development of a diverse, translational research workforce that is capable of participating and/or leading cross-disciplinary team science relevant for the treatment and prevention of Alzheimer’s disease and AD-related dementias.  The trainee will pursue a targeted research project under the mentorship of world-class researchers in the Harvard research community in three key areas:

  1. biology of aging and neurodegeneration;
  2. data sciences, computational biology, statistics, math/engineering/physics;
  3. drug discovery and development

Most T32 faculty are within the MGH Martinos Center for Biomedical Imaging and/or Massachusetts Alzheimer’s Disease Research Center.  Training includes targeted coursework, didactic lectures, and a dedicated T32 lecture series. General training includes research conduct, diversity and inclusion, mentoring, career development, and grant development activities.

Eligibility: PhD, MD, MD/PhD and U.S. citizen or permanent resident (see NIH PAR-18-524), with rolling admission for 4 training slots.  Our goal is to recruit a truly diverse T32 trainee pool that is highly representative of URM and women trainees.

Additional information: Please see  https://pricelab.martinos.org/t32-adrd/ for further information including application instructionsPlease submit questions to:  Krystal Whitfield (T32 Administrative Contact) at T32ADRD@mgh.harvard.edu

 
9. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process            
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities                                                                                                                                        
Please click here for more information and for our internal deadlines.

  • National Hemophilia Program Coordinating Center (HRSA)
  • Emerging Strategies to Improve Health Outcomes for People Aging with HIV: Demonstration Sites
  • Emerging Strategies to Improve Health Outcomes for People Aging with HIV: Capacity-Building Provider
  • Emerging Strategies to Improve Health Outcomes for People Aging with HIV: Evaluation Provider
  • Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
  • Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed)
  • SUNBEAM – Analysis and Bioinformatics Center (ABC) (UM1 Clinical Trial Not Allowed)
  • NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed)
  • NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Required)
  • NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 – Independent Basic Experimental Studies with Humans Required)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

 
10. Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard Insight/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 11/19/21

  • Basic Research Fellowships, American Brain Tumor Association (ABTA). $100,000. LOI Deadline: December 9
  • Discovery Grant, American Brain Tumor Association (ABTA). $50,000. LOI Deadline: December 9
  • Research Grant Program, American Society for Laser Medicine and Surgery (ASLMS). $70,000. Pre-Application Deadline: November 29
  • Clinical Fellowship Training Program, Dystonia Medical Research Foundation (DMRF). $65,000. Application Deadline: January 7
  • Phase I and II Clinical Trial Grant Programs, Gateway for Cancer Research. $1.5 million. LOI Deadline: February 1
  • Addressing Evidence-Based Health Benefits of Human-Animal Interaction, Human Animal Bond Research Institute (HABRI). $45,000. Application Deadline: February 24
  • Glioma Emerging Leader Grant Award, Ivy Foundation. $500,000. Application Deadline: March 1
  • Translational Adult Glioma Grant Award, Ivy Foundation. $600,000. Application Deadline: March 1
  • Hollis Brownstein Research Grants Program, Leukemia Research Foundation, Inc. $100,000. LOI Deadline: February 4
  • (Translational Sex and Gender Difference) First Look Awards, Massachusetts Life Sciences Center. $50,000. Application Deadline: January 28
  • Ann Theodore Foundation Breakthrough Sarcoidosis Initiative, Milken Institute. $575,000. Application Deadline: January 10
  • Nontraditional, Nonsurgical Treatment Grants, North American Spine Society (NASS). $50,000. Preliminary Proposal Deadline: February 7
  • Research Grants, North American Spine Society (NASS). $50,000. Preliminary Proposal Deadline: February 7
  • Young Investigator Grants, North American Spine Society (NASS). $50,000. Preliminary Proposal Deadline: February 7
 
Back to top
In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events

MGH Town Hall Meeting Recordings

MGB Community Connects

Mentor MGB

Check out the Coronavirus Resource Guide for MGH Researchers!

NIH Update for Week Ending November 19, 2021

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

Looking for something you saw in a previous Research News release? Check out our archive!

Back to top
 
RESOURCES  

ECOR Website

Mass General Research Institute

MGH Research Intranet

Research Help and How-To

Your email address is currently listed as:%%emailaddr%%.

Click here to edit your profile or to change your email address for receipt of information about MGH Research.

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114
ecor@mgh.harvard.edu